Daré Bioscience, Inc. (DARE)

Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.7	10.48	34.67	51.67	4.67
Cash & Short-Term Investments	15.7	10.48	34.67	51.67	4.67
Cash Growth	49.85%	-69.78%	-32.91%	1006.64%	-2.31%
Other Receivables	0.23	0.95	1.7	1.15	0.46
Receivables	0.23	0.95	1.7	1.15	0.46
Prepaid Expenses	2.52	6.12	6.67	2.48	1.85
Total Current Assets	18.45	17.54	43.04	55.3	6.98
Property, Plant & Equipment	2.54	1.98	0.52	0.24	0.28
Long-Term Deferred Charges	-	-	-	0.14	-
Other Long-Term Assets	1.11	1.76	0.26	0.13	0.29
Total Assets	22.1	21.28	43.83	55.81	7.55
Accounts Payable	1.46	3.39	2.03	2.1	1.02
Accrued Expenses	3.04	2.89	10.89	3.14	3.36
Short-Term Debt	-	-	-	-	0.37
Current Portion of Leases	0.55	0.47	0.4	0.27	0.35
Current Unearned Revenue	16.56	13.74	18.3	10.54	1.56
Other Current Liabilities	-	-	-	-	1
Total Current Liabilities	21.61	20.48	31.62	16.05	7.66
Long-Term Leases	0.75	0.94	0.09	-	0.04
Long-Term Unearned Revenue	5.75	4.91	1	1	1
Total Liabilities	28.11	26.33	32.71	17.05	8.7
Common Stock	0	0.01	0.01	0.01	0
Additional Paid-In Capital	169.71	166.54	152.53	149.03	70.37
Retained Earnings	-175.29	-171.24	-141.07	-110.13	-71.43
Comprehensive Income & Other	-0.43	-0.36	-0.35	-0.15	-0.09
Shareholders' Equity	-6.01	-5.05	11.11	38.75	-1.15
Total Liabilities & Equity	22.1	21.28	43.83	55.81	7.55
Total Debt	1.3	1.4	0.49	0.27	0.76
Net Cash (Debt)	14.4	9.07	34.18	51.4	3.91
Net Cash Growth	58.68%	-73.46%	-33.51%	1213.79%	-1.68%
Net Cash Per Share	1.69	1.25	4.85	10.09	1.56
Filing Date Shares Outstanding	8.85	8.38	7.18	7	3.94
Total Common Shares Outstanding	8.7	8.33	7.07	7	3.47
Working Capital	-3.16	-2.94	11.41	39.24	-0.68
Book Value Per Share	-0.69	-0.61	1.57	5.54	-0.33
Tangible Book Value	-6.01	-5.05	11.11	38.75	-1.15
Tangible Book Value Per Share	-0.69	-0.61	1.57	5.54	-0.33

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q